Mupirocin vs terbinafine in impetigo

Indian Journal of Pediatrics

Volumn 69, Issue 8, 2002, Pages 679-682

  Ciftci, Ergin ^a,b   Guriz, Haluk ^b   Aysev, Ahmet Derya ^b  

^a Pediat Clin of Elmadag Stt Hosp   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Impetigo; Mupirocin; Terbinafine

Indexed keywords

PSEUDOMONIC ACID; TERBINAFINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ERADICATION THERAPY; FEMALE; HUMAN; IMPETIGO; IMPETIGO BULLOSA; INFANT; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TOPICAL TREATMENT; TREATMENT OUTCOME;

EID: 0036672832     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02722704     Document Type: Article

References (13)

1. Ryder NS, Favre B. Antifungal activity and mechanism of action of terbinafine. Rev Contemp Pharmacother 1997; 8 : 275-287.
2. Nolting S, Brautigam M. Clinical relevance of the antibacterial activity of terbinafine: A contralateral comparison between 1% terbinafine cream and 0.1% gentamicin sulphate cream in pyoderma. Brt J Dermatol 1992; 126(Suppl. 39) : 56-60.
3. Faergemann J. Pharmacokinetics of terbinafine. Rev Contemp Pharmacother 1997; 8 : 289-297.
4. Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: Implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1992; 36 : 287-290.
5. Britton JW, Fajardo JE, Crafte-Jacobs B. Comparison of mupirocin and erythromycin in the treatment of impetigo. J Pediatr 1990; 117 : 827-829.
6. Dux PH, Fields L, Pollock D.2% topical mupirocin versus systemic erythromycin and cloxacillin in primary and secondary skin infections. Curr Ther Res 1986; 40 : 933-940.
7. Bass JW, Chan DS, Creamer KM, Thompson MW, Malone FJ, Becker TM, Marks SN. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Infect Dis J 1997; 16 : 708-710.
8. Welsh O, Saenz C. Topical mupirocin compared with oral ampicillin in the treatment of primary and secondary skin infections. Curr Ther Res 1987; 41 : 114-120.
9. White DG, Collins PO, Rowsell RB. Topical antibiotics in the treatment of superficial skin infections in general practice-a comparison of mupirocin and sodium fusidate. J Infect 1989; 18 : 221-229.
10. Leyden JJ, Kligman AM. Interdigital athlete's foot. The interaction of dermatophytes and resident bacteria. Arch Dermatol 1978; 114 : 1466-1472.
11. Brook I. Microbiology of secondarily infected diaper dermatitis. Int J Dermatol 1992; 31 : 700-702.
12. Arredondo JL. Efficacy and tolerance of topical mupirocin compared with oral dicloxacillin in the treatment of primary skin infections. Curr Ther Res 1987; 41 : 121-127.
13. Suhonen R, Neuvonen PJ. The tolerability profile of terbinafine. Rev Contemp Pharmacother 1997; 8 : 373-386.